Fleury S.A. (FLRY3.SA)

13.87 -0.01 (-0.07%) At close: 05:07PM BRT

Fleury S.A.

Avenida Morumbi
8860 – 8º andar Brooklin
São Paulo, SP 04703-003
Brazil
55 11 5014 7236
https://ri.fleury.com.br

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 27,300

Key Executives

Name	Title	Pay	Exercised	Year Born
Ms. Jeane Mike Tsutsui	CEO & President of Executive Board	N/A	N/A	N/A
Mr. Jose Antonio de Almeida Filippo	CFO, Investor Relations Officer & Member of Executive Board	N/A	N/A	1960
Mr. Claudio Almeida Prado	Executive Director of New Links & Member of Executive Board	N/A	N/A	N/A
Mr. Edgar Gil Rizzatti	Medical, Technical & Process Executive Director and Member of Executive Board	N/A	N/A	N/A
Mr. Roberto Santoro Meirelles	L2L & Operations Support Officer and Member of Executive Board	N/A	N/A	N/A
Mr. Fernando Aguiar Camargo	Secretary	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in BRL.

Description

Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including scheduling and performing teleconsultations, and face-to-face consultations, as well as scheduling and accessing diagnostic test results, electronic medical record, and self-manage health issues. It operates customer service units and hospital-based units under the Fleury, Felippe Mattoso, Labs a+, Diagnoson a+, Papaiz, Serdil, LAFE, Instituto de Radiologia de Natal, Centro de Patologia Clínica, Diagmax, Santécorp, a+SP, CIP, Saha, Moacir Cunha, Vita, e Campana, Methodos, Pretti, Bioclinico, a+PE, Marcelo Magalhaes, Inlab, Weinmann, a+, a+BA, IRN, CPC, and a+PI brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.

Corporate Governance

Fleury S.A.’s ISS Governance QualityScore as of April 1, 2024 is 10. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 6; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.